Evidence map›Paper›PMID 32390702›Full record

Observational studyWorld journal of gastroenterology2020

Interleukin-6 compared to the other Th17/Treg related cytokines in inflammatory bowel disease and colorectal cancer.

Tsvetelina Veselinova Velikova, Lyuba Miteva, Noyko Stanilov, Zoya Spassova, Spaska Angelova Stanilova

Open access · hybridAbstract readComparative StudyObservational Study
In one paragraph

Observational study in World journal of gastroenterology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 2 countries.

Tsvetelina Veselinova VelikovaClinical Immunology, University Hospital "Lozenetz", Sofia 1407, Bulgaria. tsvelikova@medfac.mu-sofia.bg.
Lyuba MitevaDepartment of Molecular Biology, Immunology and Medical Genetics, Medical Faculty, Trakia University, Stara Zagora 6000, Bulgaria.
Noyko StanilovOncoplastic Unit, University College London Hospital, London 235, United Kingdom.
Zoya SpassovaClinic of Gastroenterology, University Hospital "St. Ivan Rilski", Sofia 1431, Bulgaria.
Spaska Angelova StanilovaDepartment of Molecular Biology, Immunology and Medical Genetics, Medical Faculty, Trakia University, Stara Zagora 6000, Bulgaria.
Trakia University · BGLozenetz Hospital · BGUniversity College Hospital · GBUniversity College London · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe connection between inflammatory bowel disease (IBD) and colorectal cancer (CRC) is well-established, as persistent intestinal inflammation plays a substantial role in both disorders. Cytokines may further influence the inflammation and the carcinogenesis process.

aimTo compare cytokine patterns of active IBD patients with early and advanced CRC.

methodsChoosing a panel of cytokines crucial for Th17/Treg differentiation and behavior, in colon specimens, as mRNA biomarkers, and their serum protein levels.

resultsWe found a significant difference between higher gene expression of

conclusionOur findings showed that

Indexed as

AdultAgedAnti-Inflammatory AgentsCarcinogenesisColorectal NeoplasmsFemaleForkhead Transcription FactorsGastrointestinal AgentsGene Expression ProfilingGene Expression Regulation, NeoplasticHumansInflammatory Bowel DiseasesInterleukin-6Interleukin-6 InhibitorsIntestinal MucosaMaleAnti-Inflammatory AgentsForkhead Transcription FactorsFOXP3 protein, humanGastrointestinal AgentsIL6 protein, humanInterleukin-6Interleukin-6 InhibitorsTGFB1 protein, humanTransforming Growth Factor beta1Colorectal cancerCytokinesInflammatory bowel diseaseInterleukin-6mRNATh17/Treg cells

Identifiers

PMID32390702
PMCPMC7201144
OpenAlexW3021740767

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.